Shorter Gene Therapy Postmarket Studies ‘On The Table’

 
• By Derrick Gingery
  
Natural history or other data could help the FDA shorten gene therapy follow-up times. (Shutterstock)

More from Cell & Gene Therapies

More from Rare Diseases